Insulet (PODD) vs Stevanato Group S.p.A. (STVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Stevanato Group S.p.A. (STVN) has outperformed Insulet (PODD) over the past year, losing 19.2% versus a loss of 57.1%. Over five years, STVN leads with a -20.1% price change compared with -55.3% for PODD. Insulet is the larger company by market cap ($9.32 billion vs $5.31 billion), about 1.8 times the size.
On valuation, Insulet trades at a lower forward P/E (17.4x vs 23.1x for Stevanato Group S.p.A.).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PODD | STVN |
|---|---|---|
| Share price | $134.36 | $19.44 |
| Market cap | $9.32B | $5.31B |
| 1-day change | -0.27% | -2.11% |
| YTD return | -52.73% | -3.38% |
| 1-year return | -57.14% | -19.20% |
| 5-year return | -55.29% | -20.07% |
| P/E ratio (TTM) | 25.16 | 34.11 |
| Forward P/E | 17.38 | 23.10 |
| EPS (TTM) | $5.34 | $0.57 |
| Dividend yield | 0.00% | 0.32% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.71B | — |
| Revenue growth (YoY) | +30.73% | — |
| Net income (latest FY) | $247.10M | — |
| Gross margin | 71.63% | — |
| Operating margin | 17.50% | — |
| Net margin | 9.12% | — |
| 52-week high | $354.88 | $27.99 |
| 52-week low | $126.40 | $12.89 |
| Distance from 52-week high | -62.14% | -30.55% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +27.24% | +26.95% |
| Average volume | 1.68M | 370.27K |
| Shares outstanding | 69.35M | 49.83M |
| Employees | 5,400 | 6,010 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STVN has outperformed PODD by 37.9 percentage points over the past year.
- Stevanato Group S.p.A. trades at a higher earnings multiple (34.1x vs 25.2x trailing P/E).
About Insulet
PODD stock →Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System.
Health Care · Medical/Dental Instruments · 5,400 employees
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
PODD vs STVN FAQ
Which is bigger, Insulet or Stevanato Group S.p.A.?
Insulet (PODD) is larger, with a market capitalization of $9.32B compared with $5.31B for Stevanato Group S.p.A. (STVN).
Which stock has performed better over the past year, PODD or STVN?
STVN returned -19.20% over the past 12 months, compared with -57.14% for PODD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PODD or STVN?
PODD has the lower trailing P/E at 25.2, versus 34.1 for STVN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Insulet or Stevanato Group S.p.A.?
Stevanato Group S.p.A. pays a dividend yielding 0.32%, while Insulet does not currently pay a regular dividend.
Are Insulet and Stevanato Group S.p.A. in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.